Butterfly Network, Inc. (BFLY) vs NovoCure Limited (NVCR)
Butterfly Network, Inc. and NovoCure Limited are both Medical Devices companies. Butterfly Network, Inc. is the larger, with a market value of $2.6B against $1.9B — 1.4× the size. Butterfly Network, Inc. grew revenue faster over the last twelve months: 28.1% against 11.0%. NovoCure Limited has the higher net margin (−21.3% vs −66.7%) and the lower return on invested capital (−115.6% vs −76.6%). Across the 18 metrics below, NovoCure Limited leads on 10 and Butterfly Network, Inc. on 8.
Valuation
Profitability
| Metric | BFLY | NVCR | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.64% | 76.13% | 56.01% |
| Operating margin | (70.79%) | (22.08%) | (15.03%) |
| Net margin | (66.74%) | (21.25%) | (20.40%) |
| Free cash flow margin | (25.01%) | (3.64%) | (7.24%) |
| Return on equity | (35.46%) | (43.22%) | (15.32%) |
| Return on assets | (25.11%) | (14.56%) | (19.72%) |
| Return on invested capital | (76.64%) | (115.56%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack